Sensus Healthcare Reports 21.6% Revenue Decline and Net Loss in Q3 2025

Sensus Healthcare, Inc. reported a significant decline in financial performance for the third quarter of 2025, with revenues totaling $6.9 million, down 21.6% from $8.8 million in the same period last year. For the nine months ending September 30, 2025, the company generated $22.5 million in revenue, a decrease of 21.6% compared to $28.7 million in the prior year. The drop in revenue was attributed primarily to a reduced number of units sold, with 16 units sold in the latest quarter compared to 27 in the previous year, largely due to decreased sales to a major customer. The company's gross profit also fell sharply, from $5.2 million to $2.7 million for the quarter, reflecting a gross profit margin decline from 59.1% to 39.1%.

Operating expenses increased significantly, totaling $5.3 million for the third quarter of 2025, compared to $3.7 million in the same quarter of 2024. This rise was driven by higher general and administrative costs, which rose by 18.8% to $1.9 million, and a doubling of research and development expenses to $1.8 million, reflecting increased lobbying costs and product development efforts. The company reported a net loss of $943,000 for the third quarter, compared to a net income of $1.2 million in the same period last year. For the nine-month period, the net loss was $4.6 million, a stark contrast to the $5.1 million net income reported in 2024.

In terms of operational metrics, Sensus Healthcare's accounts receivable decreased significantly to $9.3 million from $19.7 million at the end of 2024, primarily due to lower sales and extended payment terms with its main customer. Inventory levels increased to $13.0 million, up from $10.1 million, as the company anticipates future sales growth. The company also reported a cash balance of $24.5 million as of September 30, 2025, an increase from $22.1 million at the end of 2024, indicating a stable liquidity position despite the operational challenges.

Strategically, Sensus Healthcare has been focusing on expanding its product offerings and enhancing its service capabilities. The formation of Sensus Healthcare Services, LLC, a wholly owned subsidiary, aims to provide operational healthcare services, including equipment leasing and radiation oncology oversight. The company continues to navigate a highly regulated environment, particularly in the U.S. dermatology market, where it faces challenges related to reimbursement and regulatory approvals. Looking ahead, Sensus Healthcare anticipates that its effective tax rate will differ materially from the U.S. federal statutory rate due to the favorable impact of tax credits, which may help mitigate some financial pressures.

Overall, Sensus Healthcare's recent quarterly results reflect a challenging market environment, with significant declines in revenue and profitability. The company is actively working to address these challenges through strategic initiatives and operational adjustments, while maintaining a focus on liquidity and future growth opportunities.